Healthy volunteers to test malaria drug combinations for safer treatment

NCT ID NCT07470424

First seen Mar 26, 2026 · Last updated Apr 28, 2026 · Updated 5 times

Summary

This study involves 24 healthy adults in Thailand who will take three different malaria drugs—piperaquine, pyronaridine, and artesunate—alone and together. The goal is to see how these drugs interact in the body and check for side effects. Results will help doctors use these medicines more safely and effectively for malaria patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical Therapeutic Unit, Faculty of Tropical Medicine

    Bangkok, 10400, Thailand

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.